Cargando…

On-line dose-guidance to account for inter-fractional motion during proton therapy()

BACKGROUND AND PURPOSE: Proton therapy (PT) of extra-cranial tumour sites is challenged by density changes caused by inter-fractional organ motion. In this study we investigate on-line dose-guided PT (DGPT) to account inter-fractional target motion, exemplified by internal motion in the pelvis. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Busch, Kia, Muren, Ludvig P., Thörnqvist, Sara, Andersen, Andreas G., Pedersen, Jesper, Dong, Lei, Petersen, Jørgen B.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807653/
https://www.ncbi.nlm.nih.gov/pubmed/33458420
http://dx.doi.org/10.1016/j.phro.2018.11.009
_version_ 1783636788061929472
author Busch, Kia
Muren, Ludvig P.
Thörnqvist, Sara
Andersen, Andreas G.
Pedersen, Jesper
Dong, Lei
Petersen, Jørgen B.B.
author_facet Busch, Kia
Muren, Ludvig P.
Thörnqvist, Sara
Andersen, Andreas G.
Pedersen, Jesper
Dong, Lei
Petersen, Jørgen B.B.
author_sort Busch, Kia
collection PubMed
description BACKGROUND AND PURPOSE: Proton therapy (PT) of extra-cranial tumour sites is challenged by density changes caused by inter-fractional organ motion. In this study we investigate on-line dose-guided PT (DGPT) to account inter-fractional target motion, exemplified by internal motion in the pelvis. MATERIALS AND METHODS: On-line DGPT involved re-calculating dose distributions with the isocenter shifted up to 15 mm from the position corresponding to conventional soft-tissue based image-guided PT (IGPT). The method was applied to patient models with simulated prostate/seminal vesicle target motion of ±3, ±5 and ±10 mm along the three cardinal axes. Treatment plans were created using either two lateral (gantry angles of 90°/270°) or two lateral oblique fields (gantry angles of 35°/325°). Target coverage and normal tissue doses from DGPT were compared to both soft-tissue and bony anatomy based IGPT. RESULTS: DGPT improved the dose distributions relative to soft-tissue based IGPT for 39 of 90 simulation scenarios using lateral fields and for 50 of 90 scenarios using lateral oblique fields. The greatest benefits of DGPT were seen for large motion, e.g. a median target coverage improvement of 13% was found for 10 mm anterior motion with lateral fields. DGPT also improved the dose distribution in comparison to bony anatomy IGPT in all cases. The best strategy was often to move the fields back towards the original target position prior to the simulated target motion. CONCLUSION: DGPT has the potential to better account for large inter-fractional organ motion in the pelvis than IGPT.
format Online
Article
Text
id pubmed-7807653
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78076532021-01-14 On-line dose-guidance to account for inter-fractional motion during proton therapy() Busch, Kia Muren, Ludvig P. Thörnqvist, Sara Andersen, Andreas G. Pedersen, Jesper Dong, Lei Petersen, Jørgen B.B. Phys Imaging Radiat Oncol Original Research Article BACKGROUND AND PURPOSE: Proton therapy (PT) of extra-cranial tumour sites is challenged by density changes caused by inter-fractional organ motion. In this study we investigate on-line dose-guided PT (DGPT) to account inter-fractional target motion, exemplified by internal motion in the pelvis. MATERIALS AND METHODS: On-line DGPT involved re-calculating dose distributions with the isocenter shifted up to 15 mm from the position corresponding to conventional soft-tissue based image-guided PT (IGPT). The method was applied to patient models with simulated prostate/seminal vesicle target motion of ±3, ±5 and ±10 mm along the three cardinal axes. Treatment plans were created using either two lateral (gantry angles of 90°/270°) or two lateral oblique fields (gantry angles of 35°/325°). Target coverage and normal tissue doses from DGPT were compared to both soft-tissue and bony anatomy based IGPT. RESULTS: DGPT improved the dose distributions relative to soft-tissue based IGPT for 39 of 90 simulation scenarios using lateral fields and for 50 of 90 scenarios using lateral oblique fields. The greatest benefits of DGPT were seen for large motion, e.g. a median target coverage improvement of 13% was found for 10 mm anterior motion with lateral fields. DGPT also improved the dose distribution in comparison to bony anatomy IGPT in all cases. The best strategy was often to move the fields back towards the original target position prior to the simulated target motion. CONCLUSION: DGPT has the potential to better account for large inter-fractional organ motion in the pelvis than IGPT. Elsevier 2018-12-19 /pmc/articles/PMC7807653/ /pubmed/33458420 http://dx.doi.org/10.1016/j.phro.2018.11.009 Text en © 2018 Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Busch, Kia
Muren, Ludvig P.
Thörnqvist, Sara
Andersen, Andreas G.
Pedersen, Jesper
Dong, Lei
Petersen, Jørgen B.B.
On-line dose-guidance to account for inter-fractional motion during proton therapy()
title On-line dose-guidance to account for inter-fractional motion during proton therapy()
title_full On-line dose-guidance to account for inter-fractional motion during proton therapy()
title_fullStr On-line dose-guidance to account for inter-fractional motion during proton therapy()
title_full_unstemmed On-line dose-guidance to account for inter-fractional motion during proton therapy()
title_short On-line dose-guidance to account for inter-fractional motion during proton therapy()
title_sort on-line dose-guidance to account for inter-fractional motion during proton therapy()
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807653/
https://www.ncbi.nlm.nih.gov/pubmed/33458420
http://dx.doi.org/10.1016/j.phro.2018.11.009
work_keys_str_mv AT buschkia onlinedoseguidancetoaccountforinterfractionalmotionduringprotontherapy
AT murenludvigp onlinedoseguidancetoaccountforinterfractionalmotionduringprotontherapy
AT thornqvistsara onlinedoseguidancetoaccountforinterfractionalmotionduringprotontherapy
AT andersenandreasg onlinedoseguidancetoaccountforinterfractionalmotionduringprotontherapy
AT pedersenjesper onlinedoseguidancetoaccountforinterfractionalmotionduringprotontherapy
AT donglei onlinedoseguidancetoaccountforinterfractionalmotionduringprotontherapy
AT petersenjørgenbb onlinedoseguidancetoaccountforinterfractionalmotionduringprotontherapy